Product Details
| Product Name:
Cort108297 |
CAS No.:
1018679-79-2 |
| Purity:
98% |
Supply Ability:
10g |
| Release date:
2024/11/19 |
Product Introduction
Bioactivity
| Name | Cort108297 |
| Description | Cort108297 is a selective glucocorticoid receptor modulator and a selective GR antagonist with no affinity for other steroid receptors. Cort108297 showed a high affinity for GRs (Ki: 0.45nM). |
| In vitro | Cort108297 and CORT118335 had antagonistic effects on dexamethasone-induced KLK3 expression, which were 48% (p<0.05) and 60% (p<0.05), respectively. CORT118335(1μM) inhibited dexamethasone-induced SGK1 expression by 50%. However, Cort108297 was able to completely inhibit dexamethasone-mediated SGK1 elevation (p<0.05). After 3 days of dexamethasone ±SGRMs treatment in CWR-22RV1 cells, the induction effect of SGK1 gene expression was 100 times greater than that in re treated cells, while Cort108297 and CORT118335 completely inhibited this effect (p<0.01). Cort108297 and CORT118335 inhibited 70% and 75% of induction effects, respectively (p<0.01)[1]. |
| In vivo | At the end of the treatment period, mice treated with Cort108297(40?mg/kg BID) or Cort108297 (80?mg/kg QD) also have significantly lower steady plasma glucose than mice receiving vehicle[3]. Male rats are treated for five days with Mifepristone (10 mg/kg), Cort108297 (30 mg/kg and 60 mg/kg), Imipramine (10mg/kg) or vehicle and exposed to forced swim test (FST) or restraint stress. Experimental data showed that both doses of Cort108297 can effectively inhibit corticosterone response to FST and restraint stress, while only high dose of Cort108297 (60mg/kg) can significantly reduce immobility in forced swimming test (FST). [1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 30 mg/mL (56.02 mM)
|
| Keywords | Cort108297 | Cort-108297 |
| Inhibitors Related | Nimodipine | Hydrocortisone | Mifepristone | Prednisolone acetate | Beclometasone | Cortisone | Dexamethasone acetate | Prednisolone | Dexamethasone Phosphate disodium | Prednisone acetate | Desonide | Corticosterone |
| Related Compound Libraries | Nuclear Receptor Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:863421-32-3
$68.00 / 1mg
-
CAS:52286-74-5
$48.00 / 5mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States